column graph graphpad prism version 6.0 (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
column graph graphpad prism version 6.0
Column Graph Graphpad Prism Version 6.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/column+graph+graphpad+prism+version+6%2E0/column+graph+graphpad+prism+version+6+0/10__3233_slash_cbm___203125-36-1-7
Average 90 stars, based on 1 article reviews
Column Graph Graphpad Prism Version 6.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/column+graph+graphpad+prism+version+6%2E0/column+graph+graphpad+prism+version+6+0/10__3233_slash_cbm___203125-36-1-7
Average 90 stars, based on 1 article reviews
column graph graphpad prism version 6.0 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: High FAS expression correlates with a better prognosis and efficacy of taxanes and target regents in breast cancer Article Snippet: BACKGROUND: FAS can serve as both an oncogene and a suppresser in different malignancies, and the prognostic value of FAS remains controversial.. METHODS: The Oncomine database, KM-Plotter and bc-GenExMiner platform were adopted to analyze the prognostic value of FAS in breast cancer.. Breast cancer tissue microarrays were further used to verify these data. |